[1]
“When a Deadly Disease Ironically becomes Desirable: Insights from 2023 Antimalarial Therapeutic Efficacy Studies in Nigeria”, The Nig Health J, vol. 24, no. 3, pp. 1617 – 1622, Oct. 2024, doi: 10.60787/tnhj.v24i3.879.